Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Researchers.
- Curriculum.
- Publications.
- Projects.
- Presentations.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Curcic Sanja |

Presentations at scientific and public conferences

Curcic, S; Erkan-Cadag, H; Pilic, J; Malli, R; Wiedner, P; Tiapko, O; Groschner, K TRPC3 governs the spatiotemporal organization of cellular Ca2+ signatures by functional coupling to IP3 receptors at ER–PM junctions
APHAR; SEP 29-30, 2023; Vienna, AUSTRIA. 2023. [Poster]

Groschner, K; Erkan-Candag, H; Curcic, S Dynamic communication between TRPC3 and IP3R shape Ca2+ signaling signatures
BIOPHYS J. 2023; 122(3): 235A-236A. [Poster]
Web of Science PubMed

Bacsa, B; Tiapko, O; Graziani, A; Curcic, S; Groschner, K All-Optical Analysis of TRPC3/6 Signalling in Mast Cells.
BIOPHYS J. 2020; 118(3):415A-415A.-64th Annual Meeting of the Biophysical-Society; FEB 15-19, 2020; San Diego, CA. [Poster]
Web of Science

Knuplez,E; Curcic, S; Sturm, E; Heinemann, A; Marsche, G. In vitro and in vivo inhibiton of eosinophil activation by lysophosphatidylcholine and synthetic alkyl-lysophosphatidylcholine
11th Biennial Symposium of the International Eosinophil Society; JUL 9-13; Portland, USA. 2019. [Poster]

Tiapko, O; Curcic, S; de la Cruz, GG; Glasnov, T; Groschner, K Agonist-Dependent Plasticity in the TRPC3 Selectivity Filter
BIOPHYS J. 2019; 116(3):536A-536A.-63rd Annual Meeting of the Biophysical-Society; MAR 02-06, 2019; Baltimore, MD. Doi: 10.1016/j.bpj.2018.11.2883 [Poster]
Web of Science FullText FullText_MUG

Goeritzer, M; Schlager, S; Vujic, N; Dorow, J; Curcic, S; Kolb, D; Schuligoi, R; Heinemann, A; Ceglarek, U; Radovic, B; Kratky, D Novel role for adipose triglyceride lipase in thrombogenesis
EUPLAN (European Platelet Network) Conference; Brugge, BELGIUM. 2018. [Oral Communication]

Knuplez, E; Curcic, S; Cvirn, G; Marsche, G Role of apolipoprotein C-III on platelet activation
Doctoral Day at the Medical University of Graz; NOV 28, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Knuplez, E; Curcic, S; Heinemann, A; Marsche, G The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
“Cancer, Inflammation, Immunity” Retreat Joint DK retreat MCBO/MOLIN/IAI; JAN 13-17, 2018; Obergurgl, AUSTRIA. 2018. [Poster]

Knuplez, E; Curcic, S; Heinemann, A; Marsche, G The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
DK Molin Annual Retreat 2018; APR 11-13, 2018; Schloss Seggau, Austria. 2018. [Oral Communication]

Knuplez, E; Curcic, S; Sturm, EM; Heinemann, A; Marsche, G The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
24th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 27-28, 2018; Graz, AUSTRIA. 2018. [Oral Communication]

Knuplez, E; Curcic, S; Sturm, EM; Heinemann, A; Marsche, G Lysophosphatidylcholine and its synthetic analogue miltefosine potently suppress eosinophil over-activation
WISC 2018- Personalized medicine in allergy: Biologics & Immunotherapy; DEC 05-09, 2018; Florence, ITALY. 2018. [Poster]

Schlager, S; Goeritzer, M; Vujic, N; Dorow, J; Curcic, S; Kolb, D; Schuligoi, R; Heinemann, A; Ceglarek, U; Radovic, B; Kratky, D Novel role for adipose triglyceride lipase in thrombogenesis
Joint Meeting on Inflammation and Thrombosis; MAY 15-16, 2018; Vienna, AUSTRIA. 2018. [Oral Communication]

Tiapko, O; Curcic, S; Graziani, A; Shrestha, N; Glasnov, T; de la Cruz, GG; Schindl, R; Groschner, K Control of endogenous TRPC3 channels by small molecule photoswitch OptoBI-1.
24th Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 27-28, 2018; Graz, AUSTRIA. 2018. [Poster]

Tiapko, O; Curcic, S; Graziani, A; Shrestha, N; Glasnov, T; de la Cruz, GG; Schindl, R; Groschner, K Novel small molecule photoswitches for precise control of native TRPC channels.
10th ÖGMBT Annual Meeting; SEP 17-20, 2018; Vienna, AUSTRIA. 2018. [Poster]

Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G Lysophospholipid-enriched HDL suppresses platelet activation
23rd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017. [Poster]

Curcic, S; Holzer, M; Pasterk, L; Knuplez, E; Eichmann, TO; Frank, S; Zimmermann, R; Schicho, R; Heinemann, A; Marsche, G. Secretory phospholipase A2 modified HDL potently inhibits platelet activation
9th ÖGMBT Annual Meeting; SEP 25-27, 2017; Innsbruck, AUSTRIA. 2017. [Poster]

Forstner, D; Schallmoser, K; Siwetz, M; Maninger, S; Marsche, G; Curcic, S; Gauster, M EINFLUSS VON THROMBOZYTENFAKTOREN AUF DEN VILLÖSEN TROPHOBLASTEN
Journal für Reproduktionsmedizin und Endokrinologie. 2017; -Gemeinsame Jahrestagung der Österreichischen Gesellschaft für Reproduktionsmedizin und Endokrinologie und der Österreichischen IVF-Gesellschaft; SEP 28-30, 2017; Seggau, AUSTRIA. [Oral Communication]

Knuplez, E; Curcic, S; Heinemann, A; Marsche, G The anti-cancer alkylphosphocholine drug Miltefosine potently suppresses eosinophil over-activation
Doctoral Day at the Medical University of Graz; DEC 13, 2017; Graz, AUSTRIA. 2017. [Oral Communication]

Knuplez, E; Curcic, S; Heinemann, A; Marsche, G The role of (secretory) phospholipases in eosinophil function.
DK Molin Annual Retreat; JAN 30 - FEB 1, 2017; Schloss Seggau, AUSTRIA. 2017. [Oral Communication]

Knuplez, E; Curcic, S; Heinemann, A; Marsche, G The role of lysophosphatidylcholine in eosinophil activation
23nd Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 28-29, 2017; Innsbruck, AUSTRIA. 2017. [Poster]

Knuplez, E; Curcic, S; Heinemann, A; Marsche, G Lysophosphatidylcholine suppresses eosinophil activation
9th ÖGMBT Annual Meeting & 8th Life Sciences Meeting Innsbruck; SEP 25-26, 2017; Innsbruck, AUSTRIA. 2017. [Poster]

Marsche, G; Holzer, M; Curcic, S SECRETORY PHOSPHOLIPASE A2 MODIFIED HIGH-DENSITY LIPOPROTEIN POTENTLY SUPPRESSES PLATELET ACTIVATION
ATHEROSCLEROSIS. 2017; 263: E94-E94.-85th Congress of the European-Atherosclerosis-Society (EAS); APR 23-26, 2017; Prague, CZECH REPUBLIC. Doi: 10.1016/j.atherosclerosis.2017.06.306 [Oral Communication]
Web of Science FullText FullText_MUG

Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G Secretory phospholipase A2 modified HDL suppresses platelet activation and platelet-leukocyte crosstalk
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, AUSTRIA. 2016. [Poster]

Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G Plasma Advanced-Oxidized Protein Products Promote Platelet-Endothelial Crosstalk and Endothelial Tissue Factor Expression
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7,2016; Nashville, USA. 2016. [Poster]

Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligo, R; Schicho, R; Heinemann, A; Marsche, G; The role of Plasma advanced-oxidized protein products on platelets and platelet-endothelial interactions
22nd Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 8-10, 2016; Vienna, Austria. 2016. [Poster]

Trieb, M; Horvath, A; Stadlbauer, V; Taschler, U; Curcic, S; Holzer, M; Pasterk, L; Heinemann, A; Marsche, G Liver Disease Alters HDL Composition, Metabolism and Function
Arteriosclerosis, Thrombosis and Vascular Biology (ATVB) Scientific Sessions; MAY 5-7, 2016; Nashville, USA. 2016. [Poster]

Appierto, M; Trieb, M; Pasterk, L; curcis, S; Holzer, M; Frank, S; Marsche, G Maturation of HDL is impaired in cardiovascular disease
International Student Congress 2015; JUN 4-6, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Appierto,M;Trieb, M;Pasterk, L; Curcic, S; Holzer, M; Frank, S; Marsche, G; Maturation of HDL is impaired in cardiovascular disease
AAS meeting 2015; MAY 8-9 , 2015; St. Gilgen. 2015. [Oral Communication]

Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G Neutrophil effector responses are fully suppressed by secretory phospholipase A2-modified HDL
21st Scientific Symposium of the Austrian Pharmacological Society (APHAR) ; SEP 16-18, 2015; Graz, AUSTRIA. 2015. [Poster]

Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G Secretory phospholipase A2 shows potent anti-inflammatory effects on neutrophils
22nd Annual Meeting of the Austrian Atherosclerosis Society (AAS); MAY 8-9, 2015; St. Gilgen/Wolfgangsee, AUSTRIA. 2015. [Oral Communication]

Marsche, G; Heinemann, A; Curcic, S NEUTROPHIL EFFECTOR RESPONSES ARE SUPPRESSED BY SECRETORY PHOSPHOLIPASE A(2) MODIFIED HDL
ATHEROSCLEROSIS. 2015; 241(1):E90-E90.-83rd Congress of the European-Atherosclerosis-Society (EAS); MAR 22-25, 2015; Glasgow, SCOTLAND. Doi: 10.1016/j.atherosclerosis.2015.04.316 [Poster]
Web of Science FullText FullText_MUG

Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
Mini-Symposium "The immune system in kidney and liver disease"; APR 21, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Pasterk, L; Lemesch, S; Leber, B; Trieb, M; Curcic, S; Stadlbauer, V; Schuligoi, R; Schicho,R; Heinemann, A; Marsche,G, Plasma advanced-oxidized protein products promote platelet-endothelial crosstalk and endothelial tissue factor expression
INFLAME - Symposium on Inflammation & Immunology; SEP 13-15, 2015; Graz, AUSTRIA. 2015. [Oral Communication]

Pasterk, L; Lemesch, S; Trieb, M; Curcic, S; Appierto, M; Stadlbauer, V; Schuligoi, R; Heinemann, A; Marsche, G Advanced-oxidized protein products activate platelets through CD36, promoting platelet-endothelial crosstalk and tissue factor expression
AAS meeting ; MAI 8-9, 2015; St. Gilgen, AUSTRIA. 2015. [Poster]

Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G Maturation of HDL is impaired in cardiovascular disease.
Doctoral Day 2014; DEC 10, 2014; Graz, AUSTRIA. 2014. [Oral Communication]

Appierto, M; Trieb, M; Pasterk, L; Ćurčić, S; Holzer, M;Frank, S; Marsche, G. HDL, inflammation and cardiovascular disease
DK-MOLIN Retreat ; OKT 29-30 , 2014; Seggau, AUSTRIA. 2014. [Oral Communication]

Curcic, S; Holzer, M; Frei, R; Pasterk, L; Heinemann, A; Marsche, G Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine.
Doctoral Day 2014; DEZ 10, 2014; Graz, AUSTRIA. 2014. [Poster]

Holzer, M; Schilcher, G; Trieb, M; Curcic, S; Rosenkranz, A; Marsche, G Hemodialysis and peritoneal dialysis differentially affect HDL composition and function
Symposium on Cardiac and Vascular Stiffness; SEP 26-27, 2014; Seggau, AUSTRIA. 2014. [Poster]

Holzer, M; Schilcher, M; Trieb, M; Curcic, S; Rosenkranz, A; Marsche, G Peritoneal dialysis and hemodialysis differentially modulate HDL composition and function
7th IAS Workshop on HDL - Abstract Book. 2014; -7th IAS Workshop on HDL; MAR 24-26, 2014; Rom, Italy. [Poster]

Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G Uremia-induced oxidative modifications convert plasma albumin into platelet activators
Docteral Day ; DEC 10, 2014; Graz, AUSTRIA. 2014. [Poster]

Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G Uremia-induced oxidative modifications convert plasma albumin into platelet activators.
Retreat DK-MOLIN; OCT 29-30; Seggau, Austria. 2014. [Poster]

Pasterk, L; Trieb, M; Curcic, S; Appierto, M; Schuligoi, R; Heinemann, A; Marsche, G Uremia-induced oxidative modifications convert plasma albumin into platelet activators
APHAR ; SEP 26-27; Innsbruck, AUSTRIA. 2014. [Poster]

Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche Secretory phospholipase A2 modified HDL shows potent anti-inflammatory effects on neutrophils
ZMF (Center for Medical Research) 10th Anniversary; JUL 17-18, 2014; Graz, AUSTRIA. 2014. [Poster]

Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
4th European Lipidomic Meeting; SEP 22-24; Graz, AUSTRIA. 2014. [Poster]

Sanja Curcic, Michael Holzer, Robert Frei, Lisa Pasterk, Akos Heinemann and Gunther Marsche Secretory phospholipase A2 modified HDL fully suppresses neutrophil effector responses: Central role of palmitoyl-lysophosphatydilcholine
20th Scientific Symposium of the Austrian Pharmacological Society (APHAR); SEP 26-27; Innsbruck, Austria. 2014. [Poster]

Curcic, S; Holzer, M; Frank, S; Frei, R; Heinemann, A; Marsche, G; Secretory phospholipase A2 drives reprogramming of neutrophils
Doctoral Day 2013; DEZ 9, 2013; Graz, AUSTRIA. 2013. [Poster]

Curcic, S; Holzer, M; Heinemann, A; Marsche, G Acute-phase secretory phospholipases have a potent antiinflammatory activity.
Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR); SEP 16-19, 2013; Vienna, AUSTRIA. 2013. [Oral Communication]

Holzer, M; Wolf, P; Inzinger, M; Trieb, M; Curcic, S; Pasterk, L; Weger, W; Heinemann, A; Marsche, G. Anti-psoriatic therapy recovers high-density lipoprotein composition and function
Intrinsic Activity. 2013; 1(1):-Joint Meeting of the Austrian Neuroscience Association (13th ANA Meeting) and the Austrian Pharmacological Society (19th Scientific Symposium of APHAR) ; SEP 16-19, 2013; Vienna, AUSTRIA. [Poster]
FullText

Curcic, S;Holzer, M; Schilcher, G; Rosenkranz, A; Stojakovic,T;Heinemann, A; Marsche, G; Chronic kidney disease alters anti-inflammatory properties of HDL.
Doctoral Day 2012; Dec 7, 2012; Graz, AUSTRIA. 2012. [Oral Communication]

Holzer, M; Curcic, S; El-Gamal, D; Binder, V; Schilcher, G; Rosenkranz, A; Marsche, G Peritoneal dialysis and hemodialysis differentially modulate HDL composition and function
ATHEROSCLEROSIS SUPPLEMENTS. 2012; -European Atherosclerosis Society Congress; MAI 25-28, 2012; MAILAND. [Poster]
FullText

Marsche,G; El-Gamal,D; Binder,V; Curcic,S; Holzer,M; Myeloperoxidase favors lipoprotein carbamylation: Novel pathways generating dysfunctional high-density lipoprotein
Meeting Abstract; ATHEROSCLEROSIS SUPPLEMENTS. 2012; -80th European Atherosclerosis Society Congress; MAI 28-28,2012; Milan, ITALY. [Oral Communication]

↑ Top of page / Navigation